Access the full text.
Sign up today, get DeepDyve free for 14 days.
In patients with colorectal liver metastases surgical resection is the only potentially curative therapy option, with reported 5-year-survival of up to 50%. Approximately 25% of all patients with colorectal cancer have synchronous liver metastases, which has been associated with extremely poor prognosis. Advances in hepatic surgery and improved response rates to modern chemotherapeutic and targeted agents have changed our approach to stage IV patients from palliative therapy towards an aggressive multidisciplinary strategy in curative intention. However, the optimal treatment sequence in these patients has not been clearly defined. This short review summarizes the advantages and disadvantages of three different treatment approaches in patients with newly diagnosed colorectal cancer and resectable synchronous liver metastases.
memo - Magazine of European Medical Oncology – Springer Journals
Published: Jun 30, 2011
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.